1,188 filings
Page 6 of 60
8-K
ijjayzb
5 Aug 19
VIVUS Announces Approval of Qsymia® in the Republic of Korea
7:35am
8-K
h3igf7r
26 Jun 19
Entry into a Material Definitive Agreement
4:11pm
8-K
j8s9cmq
11 Jun 19
Other Events
7:32am
8-K
mcwtc2upl1
7 Jun 19
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
hjkcs0
28 May 19
Entry into a Material Definitive Agreement
4:06pm
8-K
ump6f0
28 May 19
Other Events
7:35am
4
ke0kjapre
15 May 19
VIVUS / Mark K Oki ownership change
4:59pm
4
ro4t5m7j768ks4zyno
15 May 19
VIVUS / Santosh T Varghese ownership change
4:51pm
8-K
bbsd2ziwcihrplg w8q
15 May 19
VIVUS Partners with HarborPath Direct to Facilitate Access to PANCREAZE® for Patients Without Health Insurance
7:35am
8-K
4fpwj
3 May 19
VIVUS, Inc. Q1 2019 Earnings Conference Call
4:05pm
8-K
xtb048tv4m7 lz705
30 Apr 19
Other Events
4:16pm
8-K
ry936pi 8kml
30 Apr 19
VIVUS Reports First Quarter 2019 Financial Results
4:11pm
DEFA14A
5s1wat pw4iapvvss
17 Apr 19
Additional proxy soliciting materials
4:24pm
4/A
dx70n4
10 Apr 19
VIVUS / John P. Amos ownership change
7:06pm
CT ORDER
nflglb
19 Mar 19
Confidential treatment order
8:18am
CT ORDER
mxlcslpif0kajrqg9bg
19 Mar 19
Confidential treatment order
12:00am
8-K
20kiww54v6y
14 Mar 19
VIVUS Announces Marketing Approval of Avanafil in the Russian Federation for the Treatment of Erectile Dysfunction
7:35am